An Extension Treatment Protocol for Subjects Who Have Participated in a Study of Tivozanib Versus Sorafenib in Kidney Carcinoma (Protocol AV-951-09-301).
Clinical trial NCT01076010 · COMPLETED
Trial details
- NCT number
- NCT01076010
- Sponsor
- AVEO Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2014-07-01
- Enrollment
- 277
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.